Thestates say the pharmaceutical companies conspired with one anotherto fix prices and carve up markets for medicines among themselves,rather than compete on price. (Photo: Shutterstock)
Teva Pharmaceutical Industries Ltd. helped mastermind a sweeping conspiracy among generic-drug makersto raise the price of medicines, according to a new antitrustlawsuit filed by states that stems from a five-year investigationof the companies.
More than a dozen current and former executives at topgeneric-drug makers, including Mylan NV and a unit of Pfizer Inc.,were targeted in the lawsuit made public Friday. The suit was filedby more than 40 states and led by Connecticut Attorney GeneralWilliam Tong.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
